Amgen Inc. Selling, General and Administrative Expense
Amgen Inc. (AMGN) reported Selling, General and Administrative Expense of $1.75 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-05
- Amgen Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $1.75B, a 3.19% increase year-over-year.
- Amgen Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $1.60B, a 5.04% decline year-over-year.
- Amgen Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $1.95B, a 3.94% increase year-over-year.
- Amgen Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $1.72B, a 5.85% increase year-over-year.
- Amgen Inc. selling, general and administrative expense for fiscal 2025 was $7.05B, a 0.65% decline from fiscal 2024.
- Amgen Inc. selling, general and administrative expense for fiscal 2024 was $7.10B, a 14.84% increase from fiscal 2023.
- Amgen Inc. selling, general and administrative expense for fiscal 2023 was $6.18B, a 14.13% increase from fiscal 2022.
- Amgen Inc. selling, general and administrative expense for fiscal 2022 was $5.41B, a 0.86% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.75B 10-Q · filed 2026-08-05 | $3.35B 10-Q · filed 2026-08-05 | $5.30B derived: sum of 3 quarters · filed 2026-08-05 | $7.02B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $1.60B 10-Q · filed 2026-05-01 | $3.55B derived: sum of 2 quarters · filed 2026-05-01 | $5.27B derived: sum of 3 quarters · filed 2026-05-01 | $6.96B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $1.95B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $3.67B derived: sum of 2 quarters · filed 2026-02-13 | $5.36B derived: sum of 3 quarters · filed 2026-08-05 | $7.05B 10-K · filed 2026-02-13 | ||||
| 2025-09-30 | $1.72B 10-Q · filed 2025-11-05 | $3.41B derived: sum of 2 quarters · filed 2026-08-05 | $5.10B 10-Q · filed 2025-11-05 | $6.98B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $1.69B 10-Q · filed 2026-08-05 | $3.38B 10-Q · filed 2026-08-05 | $5.26B derived: sum of 3 quarters · filed 2026-08-05 | $6.88B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $1.69B 10-Q · filed 2026-05-01 | $3.56B derived: sum of 2 quarters · filed 2026-05-01 | $5.19B derived: sum of 3 quarters · filed 2026-05-01 | $6.97B derived: sum of 4 quarters · filed 2026-05-01 | ||||
| 2024-12-31 | $1.88B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $3.50B derived: sum of 2 quarters · filed 2026-02-13 | $5.29B derived: sum of 3 quarters · filed 2026-02-13 | $7.10B 10-K · filed 2026-02-13 | ||||
| 2024-09-30 | $1.63B 10-Q · filed 2025-11-05 | $3.41B derived: sum of 2 quarters · filed 2025-11-05 | $5.22B 10-Q · filed 2025-11-05 | $7.49B derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-06-30 | $1.78B 10-Q · filed 2025-08-06 | $3.59B 10-Q · filed 2025-08-06 | $5.87B derived: sum of 3 quarters · filed 2026-02-13 | $7.22B derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-03-31 | $1.81B 10-Q · filed 2025-05-02 | $4.08B derived: sum of 2 quarters · filed 2026-02-13 | $5.43B derived: sum of 3 quarters · filed 2026-02-13 | $6.73B derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2023-12-31 | $2.27B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $3.63B derived: sum of 2 quarters · filed 2026-02-13 | $4.92B derived: sum of 3 quarters · filed 2026-02-13 | $6.18B 10-K · filed 2026-02-13 | ||||
| 2023-09-30 | $1.35B 10-Q · filed 2024-10-31 | $2.65B derived: sum of 2 quarters · filed 2024-10-31 | $3.90B 10-Q · filed 2024-10-31 | $5.48B derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-06-30 | $1.29B 10-Q · filed 2024-08-07 | $2.55B 10-Q · filed 2024-08-07 | $4.12B derived: sum of 3 quarters · filed 2025-02-14 | $5.41B derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-03-31 | $1.26B 10-Q · filed 2024-05-03 | $2.83B derived: sum of 2 quarters · filed 2025-02-14 | $4.12B derived: sum of 3 quarters · filed 2025-02-14 | $5.44B derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2022-12-31 | $1.57B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $2.86B derived: sum of 2 quarters · filed 2025-02-14 | $4.19B derived: sum of 3 quarters · filed 2025-02-14 | $5.41B 10-K · filed 2025-02-14 | ||||
| 2022-09-30 | $1.29B 10-Q · filed 2023-10-31 | $2.61B derived: sum of 2 quarters · filed 2023-10-31 | $3.84B 10-Q · filed 2023-10-31 | $5.27B derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | $1.33B 10-Q · filed 2023-08-04 | $2.56B 10-Q · filed 2023-08-04 | $3.98B derived: sum of 3 quarters · filed 2024-02-14 | $5.29B derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | $1.23B 10-Q · filed 2023-04-28 | $2.65B derived: sum of 2 quarters · filed 2024-02-14 | $3.96B derived: sum of 3 quarters · filed 2024-02-14 | $5.34B derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | $1.43B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $2.73B derived: sum of 2 quarters · filed 2024-02-14 | $4.11B derived: sum of 3 quarters · filed 2024-02-14 | $5.37B 10-K · filed 2024-02-14 | ||||
| 2021-09-30 | $1.30B 10-Q · filed 2022-11-04 | $2.69B derived: sum of 2 quarters · filed 2022-11-04 | $3.94B 10-Q · filed 2022-11-04 | $5.72B derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-06-30 | $1.38B 10-Q · filed 2022-08-05 | $2.64B 10-Q · filed 2022-08-05 | $4.41B derived: sum of 3 quarters · filed 2023-02-09 | $5.76B derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-03-31 | $1.25B 10-Q · filed 2022-04-28 | $3.03B derived: sum of 2 quarters · filed 2023-02-09 | $4.37B derived: sum of 3 quarters · filed 2023-02-09 | $5.67B derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2020-12-31 | $1.77B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $3.12B derived: sum of 2 quarters · filed 2023-02-09 | $4.41B derived: sum of 3 quarters · filed 2023-02-09 | $5.73B 10-K · filed 2023-02-09 | ||||
| 2020-09-30 | $1.35B 10-Q · filed 2021-11-03 | $2.64B derived: sum of 2 quarters · filed 2021-11-03 | $3.96B 10-Q · filed 2021-11-03 | $5.47B derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-06-30 | $1.29B 10-Q · filed 2021-08-04 | $2.61B 10-Q · filed 2021-08-04 | $4.12B derived: sum of 3 quarters · filed 2022-02-16 | $5.35B derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-03-31 | $1.32B 10-Q · filed 2021-04-28 | $2.83B derived: sum of 2 quarters · filed 2022-02-16 | $4.05B derived: sum of 3 quarters · filed 2022-02-16 | $5.31B derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2019-12-31 | $1.51B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $2.74B derived: sum of 2 quarters · filed 2022-02-16 | $4.00B derived: sum of 3 quarters · filed 2022-02-16 | $5.15B 10-K · filed 2022-02-16 | ||||
| 2019-09-30 | $1.22B 10-Q · filed 2020-10-29 | $2.48B derived: sum of 2 quarters · filed 2020-10-29 | $3.64B 10-Q · filed 2020-10-29 | $5.20B derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2019-06-30 | $1.26B 10-Q · filed 2020-07-29 | $2.41B 10-Q · filed 2020-07-29 | $3.97B derived: sum of 3 quarters · filed 2021-02-09 | $5.27B derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2019-03-31 | $1.15B 10-Q · filed 2020-05-01 | $2.71B derived: sum of 2 quarters · filed 2021-02-09 | $4.01B derived: sum of 3 quarters · filed 2021-02-09 | $5.36B derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2018-12-31 | $1.56B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $2.85B derived: sum of 2 quarters · filed 2021-02-09 | $4.21B derived: sum of 3 quarters · filed 2021-02-09 | $5.33B 10-K · filed 2021-02-09 | ||||
| 2018-09-30 | $1.29B 10-Q · filed 2019-10-30 | $2.65B derived: sum of 2 quarters · filed 2019-10-30 | $3.77B 10-Q · filed 2019-10-30 | $5.20B derived: sum of 4 quarters · filed 2020-02-12 | ||||
| 2018-06-30 | $1.35B 10-Q · filed 2019-07-31 | $2.48B 10-Q · filed 2019-07-31 | $3.91B derived: sum of 3 quarters · filed 2020-02-12 | $5.08B derived: sum of 4 quarters · filed 2020-02-12 | ||||
| 2018-03-31 | $1.13B 10-Q · filed 2019-05-01 | $2.55B derived: sum of 2 quarters · filed 2020-02-12 | $3.72B derived: sum of 3 quarters · filed 2020-02-12 | $4.93B derived: sum of 4 quarters · filed 2020-02-12 | ||||
| 2017-12-31 | $1.43B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $2.60B derived: sum of 2 quarters · filed 2020-02-12 | $3.81B derived: sum of 3 quarters · filed 2020-02-12 | $4.87B 10-K · filed 2020-02-12 | ||||
| 2017-09-30 | $1.17B 10-Q · filed 2018-10-31 | $2.38B derived: sum of 2 quarters · filed 2018-10-31 | $3.44B 10-Q · filed 2018-10-31 | $4.77B derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-06-30 | $1.21B 10-Q · filed 2018-07-27 | $2.27B 10-Q · filed 2018-07-27 | $3.60B derived: sum of 3 quarters · filed 2019-02-13 | $4.84B derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-03-31 | $1.06B 10-Q · filed 2018-04-25 | $2.39B derived: sum of 2 quarters · filed 2019-02-13 | $3.63B derived: sum of 3 quarters · filed 2019-02-13 | $4.92B derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2016-12-31 | $1.32B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $2.57B derived: sum of 2 quarters · filed 2019-02-13 | $3.86B derived: sum of 3 quarters · filed 2019-02-13 | $5.06B 10-K · filed 2019-02-13 | ||||
| 2016-09-30 | $1.24B 10-Q · filed 2017-10-26 | $2.54B derived: sum of 2 quarters · filed 2017-10-26 | $3.74B 10-Q · filed 2017-10-26 | $5.16B derived: sum of 4 quarters · filed 2018-02-13 | ||||
| 2016-06-30 | $1.29B 10-Q · filed 2017-07-26 | $2.50B 10-Q · filed 2017-07-26 | $3.91B derived: sum of 3 quarters · filed 2018-02-13 | $5.16B derived: sum of 4 quarters · filed 2018-02-13 | ||||
| 2016-03-31 | $1.20B 10-Q · filed 2017-04-27 | $2.62B derived: sum of 2 quarters · filed 2018-02-13 | $3.86B derived: sum of 3 quarters · filed 2018-02-13 | $5.02B derived: sum of 4 quarters · filed 2018-02-13 | ||||
| 2015-12-31 | $1.42B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $2.66B derived: sum of 2 quarters · filed 2018-02-13 | $3.82B derived: sum of 3 quarters · filed 2018-02-13 | $4.85B 10-K · filed 2018-02-13 | ||||
| 2015-09-30 | $1.24B 10-Q · filed 2016-10-28 | $2.40B derived: sum of 2 quarters · filed 2016-10-28 | $3.43B 10-Q · filed 2016-10-28 | $4.76B derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2015-06-30 | $1.16B 10-Q · filed 2016-07-29 | $2.19B 10-Q · filed 2016-07-29 | $3.51B derived: sum of 3 quarters · filed 2017-02-14 | $4.73B derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2015-03-31 | $1.03B 10-Q · filed 2016-05-02 | $2.35B derived: sum of 2 quarters · filed 2017-02-14 | $3.57B derived: sum of 3 quarters · filed 2017-02-14 | $4.70B derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2014-12-31 | $1.33B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $2.54B derived: sum of 2 quarters · filed 2017-02-14 | $3.68B derived: sum of 3 quarters · filed 2017-02-14 | $4.70B 10-K · filed 2017-02-14 | ||||
| 2014-09-30 | $1.21B 10-Q · filed 2015-11-02 | $2.35B derived: sum of 2 quarters · filed 2015-11-02 | $3.37B 10-Q · filed 2015-11-02 | $4.89B derived: sum of 4 quarters · filed 2016-10-31 | ||||
| 2014-06-30 | $1.14B 10-Q · filed 2015-08-05 | $2.16B 10-Q · filed 2015-08-05 | $3.68B derived: sum of 3 quarters · filed 2016-10-31 | $4.93B derived: sum of 4 quarters · filed 2016-10-31 | ||||
| 2014-03-31 | $1.02B 10-Q · filed 2015-04-27 | $2.54B derived: sum of 2 quarters · filed 2016-10-31 | $3.79B derived: sum of 3 quarters · filed 2016-10-31 | $5.05B derived: sum of 4 quarters · filed 2016-10-31 | ||||
| 2013-12-31 | $1.52B derived: 8-K 12 month − 10-Q 9 month · filed 2016-10-31 | $2.77B derived: sum of 2 quarters · filed 2016-10-31 | $4.03B derived: sum of 3 quarters · filed 2016-10-31 | $5.18B 8-K · filed 2016-10-31 | ||||
| 2013-09-30 | $1.25B 10-Q · filed 2014-10-29 | $2.50B derived: sum of 2 quarters · filed 2014-10-29 | $3.66B 10-Q · filed 2014-10-29 | $5.04B derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2013-06-30 | $1.26B 10-Q · filed 2014-08-05 | $2.41B 10-Q · filed 2014-08-05 | $3.79B derived: sum of 3 quarters · filed 2015-02-19 | $4.92B derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2013-03-31 | $1.16B 10-Q · filed 2014-04-30 | $2.53B derived: sum of 2 quarters · filed 2015-02-19 | $3.66B derived: sum of 3 quarters · filed 2015-02-19 | $4.89B derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2012-12-31 | $1.37B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | $2.50B derived: sum of 2 quarters · filed 2015-02-19 | $3.73B derived: sum of 3 quarters · filed 2015-02-19 | $4.81B 10-K · filed 2015-02-19 | $4.80B 10-K · filed 2013-02-27 | |||
| 2012-09-30 | $1.13B 10-Q · filed 2013-10-29 | $1.13B 10-Q · filed 2012-11-06 | $2.36B derived: sum of 2 quarters · filed 2013-10-29 | $3.44B 10-Q · filed 2013-10-29 | $3.43B 10-Q · filed 2012-11-06 | $4.66B derived: sum of 4 quarters · filed 2014-02-24 | ||
| 2012-06-30 | $1.23B 10-Q · filed 2013-08-06 | $1.23B 10-Q · filed 2012-08-08 | $2.31B 10-Q · filed 2013-08-06 | $2.30B 10-Q · filed 2012-08-08 | $3.53B derived: sum of 3 quarters · filed 2014-02-24 | $4.66B derived: sum of 4 quarters · filed 2014-02-24 | ||
| 2012-03-31 | $1.08B 10-Q · filed 2013-05-03 | $1.08B 10-Q · filed 2012-05-08 | $2.30B derived: sum of 2 quarters · filed 2014-02-24 | $3.42B derived: sum of 3 quarters · filed 2014-02-24 | $4.55B derived: sum of 4 quarters · filed 2014-02-24 | |||
| 2011-12-31 | $1.22B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $2.35B derived: sum of 2 quarters · filed 2014-02-24 | $3.48B derived: sum of 3 quarters · filed 2014-02-24 | $4.50B 10-K · filed 2014-02-24 | $4.49B 10-K · filed 2012-02-29 | |||
| 2011-09-30 | $1.13B 10-Q · filed 2012-11-06 | $2.25B derived: sum of 2 quarters · filed 2012-11-06 | $3.28B 10-Q · filed 2012-11-06 | $4.43B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | $1.13B 10-Q · filed 2012-08-08 | $2.15B 10-Q · filed 2012-08-08 | $3.31B derived: sum of 3 quarters · filed 2013-02-27 | $4.27B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-31 | $1.02B 10-Q · filed 2012-05-08 | $2.18B derived: sum of 2 quarters · filed 2013-02-27 | $3.14B derived: sum of 3 quarters · filed 2013-02-27 | $4.12B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | $1.16B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $2.11B derived: sum of 2 quarters · filed 2013-02-27 | $3.10B derived: sum of 3 quarters · filed 2013-02-27 | $3.98B 10-K · filed 2013-02-27 | ||||
| 2010-09-30 | $957.00M 10-Q · filed 2011-11-04 | $1.94B derived: sum of 2 quarters · filed 2011-11-04 | $2.83B 10-Q · filed 2011-11-04 | $4.01B derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-06-30 | $986.00M 10-Q · filed 2011-08-08 | $1.87B 10-Q · filed 2011-08-08 | $3.05B derived: sum of 3 quarters · filed 2012-02-29 | $3.98B derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-03-31 | $884.00M 10-Q · filed 2011-05-10 | $2.06B derived: sum of 2 quarters · filed 2012-02-29 | $3.00B derived: sum of 3 quarters · filed 2012-02-29 | $3.91B derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2009-12-31 | $1.18B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $2.11B derived: sum of 2 quarters · filed 2012-02-29 | $3.02B derived: sum of 3 quarters · filed 2012-02-29 | $3.82B 10-K · filed 2012-02-29 | ||||
| 2009-09-30 | $932.00M 10-Q · filed 2010-11-08 | $1.84B derived: sum of 2 quarters · filed 2010-11-08 | $2.64B 10-Q · filed 2010-11-08 | $3.75B derived: sum of 4 quarters · filed 2011-02-25 | ||||
| 2009-06-30 | $910.00M 10-Q · filed 2010-08-09 | $1.71B 10-Q · filed 2010-08-09 | $2.82B derived: sum of 3 quarters · filed 2011-02-25 | $3.72B derived: sum of 4 quarters · filed 2011-02-25 | ||||
| 2009-03-31 | $798.00M 10-Q · filed 2010-05-07 | $1.91B derived: sum of 2 quarters · filed 2011-02-25 | $2.81B derived: sum of 3 quarters · filed 2011-02-25 | $3.71B derived: sum of 4 quarters · filed 2011-02-25 | ||||
| 2008-12-31 | $1.11B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $2.01B derived: sum of 2 quarters · filed 2011-02-25 | $2.92B derived: sum of 3 quarters · filed 2011-02-25 | $3.79B 10-K · filed 2011-02-25 | ||||
| 2008-09-30 | $900.00M 10-Q · filed 2009-11-06 | $1.80B derived: sum of 2 quarters · filed 2009-11-06 | $2.68B 10-Q · filed 2009-11-06 | |||||
| 2008-06-30 | $904.00M 10-Q · filed 2009-08-10 | $1.78B 10-Q · filed 2009-08-10 | ||||||
| 2007-12-31 | $3.36B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |